Literature DB >> 14642809

Beneficial properties of single-domain antibody fragments for application in immunoaffinity purification and immuno-perfusion chromatography.

P Verheesen1, M R ten Haaft, N Lindner, C T Verrips, J J W de Haard.   

Abstract

We explored the possibility to apply single-domain antibodies from Camelidae for immunoaffinity purification of the ice structuring protein (ISP) from Lolium perenne, which modifies ice crystal growth and therefore has potential application in medicine, biotechnology, agriculture and (frozen) foods. Using phage display together with an appropriate selection method, a group of candidate fragments was isolated from a llama-derived immune library. Affinity chromatography using a purposely selected antibody coupled to a matrix yielded a completely pure and functional ISP. Due to the extreme refolding capabilities and physical stability of single-domain antibodies, the affinity matrix could be regenerated more than 2000 times without loss of capacity, while the fragment's monomeric nature permitted an efficient elution of antigen. The results of this study show that highly pure proteins can be recovered from biological material in a single-step process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642809     DOI: 10.1016/j.bbagen.2003.09.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection.

Authors:  Hans J W De Haard; Sandra Bezemer; Aat M Ledeboer; Wally H Müller; Piet J Boender; Sylvain Moineau; Marie-Cecile Coppelmans; Arie J Verkleij; Leon G J Frenken; C Theo Verrips
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

2.  Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: prospects for therapeutic applications.

Authors:  Mohamed El Khattabi; Hendrik Adams; Erik Heezius; Pim Hermans; Frank Detmers; Bram Maassen; Peter van der Ley; Jan Tommassen; Theo Verrips; Jord Stam
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

3.  Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library.

Authors:  Ellen R Goldman; George P Anderson; Jinny L Liu; James B Delehanty; Laura J Sherwood; Lisa E Osborn; Larry B Cummins; Andrew Hayhurst
Journal:  Anal Chem       Date:  2006-12-15       Impact factor: 6.986

4.  Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo.

Authors:  Edward Dolk; Marcel van der Vaart; David Lutje Hulsik; Gert Vriend; Hans de Haard; Silvia Spinelli; Christian Cambillau; Leon Frenken; Theo Verrips
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

5.  Characterization of camel nanobodies specific for superfolder GFP fusion proteins.

Authors:  Aya Twair; Souad Al-Okla; Moutaz Zarkawi; Abdul Qader Abbady
Journal:  Mol Biol Rep       Date:  2014-08-02       Impact factor: 2.316

Review 6.  Biotechnological applications of recombinant single-domain antibody fragments.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2011-06-09       Impact factor: 5.328

7.  Ricin detection using phage displayed single domain antibodies.

Authors:  Ellen R Goldman; Jinny L Liu; Rachael D Bernstein; Marla D Swain; Stanley Q Mitchell; George P Anderson
Journal:  Sensors (Basel)       Date:  2009-01-19       Impact factor: 3.576

8.  Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.

Authors:  Nika Strokappe; Agnieszka Szynol; Marlèn Aasa-Chapman; Andrea Gorlani; Anna Forsman Quigley; David Lutje Hulsik; Lei Chen; Robin Weiss; Hans de Haard; Theo Verrips
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

9.  Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.

Authors:  Anna Forsman; Els Beirnaert; Marlén M I Aasa-Chapman; Bart Hoorelbeke; Karolin Hijazi; Willie Koh; Vanessa Tack; Agnieszka Szynol; Charles Kelly; Aine McKnight; Theo Verrips; Hans de Haard; Robin A Weiss
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

10.  High-affinity target binding engineered via fusion of a single-domain antibody fragment with a ligand-tailored SH3 domain.

Authors:  Annika Järviluoma; Tomas Strandin; Sebastian Lülf; Jérôme Bouchet; Anna R Mäkelä; Matthias Geyer; Serge Benichou; Kalle Saksela
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.